1. Home
  2. LCNB vs TNXP Comparison

LCNB vs TNXP Comparison

Compare LCNB & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

N/A

Current Price

$19.44

Market Cap

223.1M

Sector

Finance

ML Signal

N/A

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$11.70

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCNB
TNXP
Founded
1877
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
199.7M
IPO Year
1999
2008

Fundamental Metrics

Financial Performance
Metric
LCNB
TNXP
Price
$19.44
$11.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.5K
409.5K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
5.43%
N/A
EPS Growth
68.04
91.75
EPS
0.84
N/A
Revenue
$6,445,000.00
$13,107,000.00
Revenue This Year
$8.50
$558.11
Revenue Next Year
$3.66
$38.29
P/E Ratio
$23.18
N/A
Revenue Growth
N/A
29.85
52 Week Low
$14.31
$9.40
52 Week High
$21.32
$29.19

Technical Indicators

Market Signals
Indicator
LCNB
TNXP
Relative Strength Index (RSI) 52.32 37.71
Support Level $19.01 $9.72
Resistance Level $20.48 $13.18
Average True Range (ATR) 0.45 0.65
MACD -0.01 -0.27
Stochastic Oscillator 79.49 3.36

Price Performance

Historical Comparison
LCNB
TNXP

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: